Michael A Gordon
Overview
Explore the profile of Michael A Gordon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
1004
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
YaDeau J, Soffin E, Tseng A, Zhong H, Dines D, Dines J, et al.
Clin Orthop Relat Res
. 2021 Mar;
479(8):1740-1751.
PMID: 33720071
Background: Patients often have moderate to severe pain after rotator cuff surgery, despite receiving analgesics and nerve blocks. There are many suggested ways to improve pain after rotator cuff surgery,...
2.
YaDeau J, Kahn R, Lin Y, Goytizolo E, Gordon M, Gadulov Y, et al.
HSS J
. 2019 Jul;
15(2):167-175.
PMID: 31327949
Background: General anesthesia with neuromuscular blockade may facilitate total shoulder arthroplasty but appears to increase risk of cerebral oxygen desaturation. Cerebral desaturation is undesirable and is a proxy for risk...
3.
YaDeau J, Dines D, Liu S, Gordon M, Goytizolo E, Lin Y, et al.
Clin Orthop Relat Res
. 2019 Feb;
477(3):622-632.
PMID: 30762694
Background: The pain experience for total shoulder arthroplasty (TSA) patients in the first 2 weeks after surgery has not been well described. Many approaches to pain management have been used,...
4.
Gordon M, Babbs B, Cochrane D, Bitler B, Richer J
Mol Carcinog
. 2018 Oct;
58(2):196-205.
PMID: 30294913
Ovarian cancer metastasizes via direct seeding, whereby cancer cells shed from the primary site, resist cell death in the peritoneal cavity, then metastasize to peritoneal organs. We sought to identify...
5.
Rogers T, Christenson J, Greene L, ONeill K, Williams M, Gordon M, et al.
Mol Cancer Res
. 2018 Sep;
17(1):30-41.
PMID: 30213797
Tryptophan-2,3-dioxygenase (TDO2), a rate-limiting enzyme in the tryptophan catabolism pathway, is induced in triple-negative breast cancer (TNBC) by inflammatory signals and anchorage-independent conditions. TNBCs express extremely low levels of the...
6.
Barton V, Christenson J, Gordon M, Greene L, Rogers T, Butterfield K, et al.
Cancer Res
. 2017 May;
77(13):3455-3466.
PMID: 28512248
Preclinical and early clinical trials indicate that up to 50% of triple-negative breast cancers (TNBC) express androgen receptor (AR) and are potentially responsive to antiandrogens. However, the function of AR...
7.
Gordon M, DAmato N, Gu H, Babbs B, Wulfkuhle J, Petricoin E, et al.
Mol Cancer Ther
. 2017 May;
16(7):1389-1400.
PMID: 28468774
The androgen receptor (AR) is widely expressed in breast cancer, and evidence suggests dependence on AR signaling for growth and survival. AR antagonists such as enzalutamide and seviteronel have shown...
8.
Heinz R, Rudolph M, Ramanathan P, Spoelstra N, Butterfield K, Webb P, et al.
Development
. 2016 Oct;
143(22):4236-4248.
PMID: 27729410
Profiling of RNA from mouse mammary epithelial cells (MECs) isolated on pregnancy day (P)14 and lactation day (L)2 revealed that the majority of differentially expressed microRNA declined precipitously between late...
9.
DAmato N, Gordon M, Babbs B, Spoelstra N, Carson Butterfield K, Torkko K, et al.
Mol Cancer Res
. 2016 Aug;
14(11):1054-1067.
PMID: 27565181
Implications: This study suggests that AR plays a previously unrecognized role in supporting E2-mediated ER activity in ER/AR breast cancer cells, and that enzalutamide may be an effective therapeutic in...
10.
Barton V, Gordon M, Richer J, Elias A
Ther Adv Med Oncol
. 2016 Aug;
8(4):305-8.
PMID: 27482289
No abstract available.